Everything below concerns Ac-LKKTETQ. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2026-03-16. Numbers and descriptions here follow the published literature rather than marketing material.
Regulatory status differs by country, but TB-500 is not an approved pharmaceutical in major jurisdictions. It is commonly sold as a research chemical for laboratory use, which places responsibility for identity and purity on the supplier and the laboratory. Published human data are limited, and most reports involve preclinical models or cell culture. Questions about whether the fragment mimics all actions of thymosin beta-4, and under which conditions, remain open. Independent verification of any material is therefore a practical requirement in research settings.
TB-500 is a synthetic heptapeptide with the sequence Ac-LKKTETQ. It corresponds to a short N-terminal region of thymosin beta-4, a 43-amino-acid protein found in many cell types. The fragment contains an actin-binding motif, which is one reason it appears in laboratory studies of cell migration and cytoskeletal dynamics. TB-500 is not the full-length protein and is produced as a research chemical rather than an approved therapeutic agent. Its molecular weight is approximately 889 Da.
Identity and purity checks for peptide material typically combine reversed-phase high-performance liquid chromatography with mass measurement, since retention time alone cannot confirm a sequence. Mass measurement verifies the expected molecular mass within instrument tolerance, while chromatographic peak area provides a purity estimate. Anti-doping analysis of urine uses related but more sensitive workflows, sometimes after solid-phase extraction. For research material, batch documentation, certificate content, and independent testing are common points of scrutiny, because supply chains outside pharmaceutical regulation vary widely in the paperwork they provide.
Reconstitution of a lyophilized peptide is normally done with sterile water or a suitable buffer under aseptic conditions. Adding solvent down the vial wall and allowing gentle dissolution instead of vigorous vortexing reduces the chance of aggregation, which can lower the effective concentration of the resulting solution. Concentrated stocks are usually diluted into working buffer shortly before use. Because no standard preparation protocol exists for TB-500 specifically, laboratories adapt general peptide handling practice, and reported results may reflect differing preparation choices.
Dry peptide powder is commonly kept at −20 °C in a desiccated container away from light, a practice that limits moisture uptake and oxidation. Once dissolved, solutions are generally held at 2–8 °C for short periods or frozen at −20 °C or lower for longer storage, with repeated freeze-thaw cycles avoided. Hydrolysis and oxidation are the main degradation routes for peptides in solution, and both accelerate at higher temperature or extreme pH. Published stability data specific to TB-500 are limited, so shelf life should be treated as uncertain.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C38H68N10O14 | Calculated for the acetylated heptapeptide |
| Molecular weight | ~889 Da | Monoisotopic mass approximately 889.0 Da |
| Amino acid sequence | Ac-LKKTETQ | N-terminal acetylated seven-residue peptide |
| Appearance | White to off-white powder | Typically supplied as a lyophilized solid |
| Solubility class | Water-soluble | Peptides of this size generally dissolve in aqueous media |
Lyophilised material is stable for extended periods when kept dry and cold, and suppliers typically recommend storage well below freezing. Once dissolved, the peptide is handled at refrigeration temperatures and used within a short period, because peptide bonds and the acetylated terminus can be affected by repeated freeze-thaw cycles, proteases, or extreme pH. Bacteriostatic water and saline are both described as solvents, although preservatives can interfere with some analytical workflows. Reconstituted solutions are inspected for particulates before use.
Sports authorities classify the peptide as a prohibited substance, and it appears on the World Anti-Doping Agency list under peptide hormones, growth factors, and related substances. Racing jurisdictions for horses and dogs have issued separate restrictions, and several national bodies treat it as a controlled or prescription-only item. As a research chemical it is sold without a therapeutic indication, and labels usually state that the product is not for human or veterinary use. Regulatory treatment therefore varies by country.
Detection in biological matrices generally relies on liquid chromatography coupled with tandem mass spectrometry, because the peptide lacks a convenient ultraviolet chromophore beyond the amide backbone. Immunoassays have been described, but antibodies raised against the fragment can cross-react with the full-length protein or with unrelated peptides, so findings usually require confirmation by a second technique. Sample preparation typically involves protein precipitation followed by solid-phase extraction. Reported detection windows depend on dose, route, matrix, and instrument sensitivity.
TB-500 is a synthetic seven-residue peptide whose sequence, LKKTETQ, matches the N-terminal actin-binding region of thymosin beta-4. It is usually supplied in an N-terminally acetylated form, a modification that blocks the free amino terminus and can influence behavior in solution. In the research literature the same sequence appears under several names, including thymosin beta-4 fragment and shortened thymosin beta-4. Because it is a short peptide rather than the full 43-residue parent protein, its measured properties differ from those reported for thymosin beta-4 as a whole, and the two are not interchangeable in experimental design.
Thymosin beta-4 itself is a small, widely expressed protein that sequesters monomeric actin and participates in cell migration, angiogenesis, and tissue repair. Researchers have examined the shortened fragment as a possible mimic of some of these activities, reasoning that the actin-binding motif lies within the first few residues. Binding to monomeric actin has been observed in cell-free systems. Whether the fragment reproduces the broader effects of the full protein in living tissue remains an open question, and findings from animal models are frequently cited without a clear bridge to human physiology.
Peptide bonds are susceptible to hydrolysis under extreme pH and to enzymatic cleavage if proteases are present. Heat, oxidising agents, and prolonged exposure to light also contribute to loss of material. Aggregation can occur at high concentrations or in certain buffer systems, and it may not be visible to the eye. Storage at -20 C or below is typical for both powder and aliquoted solutions, and desiccation of the powder is preferred.
Identity and purity are usually assessed by reversed-phase high-performance liquid chromatography together with mass spectrometry. The chromatogram provides a purity estimate as a percentage of total peak area, while the mass spectrum confirms that the observed mass matches the expected value. Amino acid analysis or tandem mass spectrometry sequencing can provide additional confirmation. Reported purity figures depend on the column, gradient, and detection wavelength, so values from different laboratories are not directly comparable without method details.
Lyophilised peptide is normally reconstituted with sterile water or a neutral buffer shortly before use. Because repeated freeze-thaw cycles can degrade the material, dividing a reconstituted solution into single-use aliquots is a common practice. Working solutions are usually kept cold and protected from light. The exact shelf life depends on concentration, buffer composition, and handling, so it is often determined empirically rather than assumed.
With opposition from employers and individuals to such a large peacetime liability, the target of 15,000 volunteers proved over-ambitious and the force peaked at 4,262 in October 1963, then dropping to around 2,400 by 1968. Nevertheless, the first batch of these so-called 'Ever Readies' was sent to Libya in 1963, followed by 200 to the Far East later that year. In 1965, 175 were called out, the majority deploying to Aden, where one of their officers, Lieutenant Mike Smith, won an MC.
=== Raw materials === There are roughly 13,000 compounds used in China and over 100,000 TCM recipes recorded in the ancient literature. Plant elements and extracts are by far the most common elements used. In the classic Handbook of Traditional Drugs from 1941, 517 drugs were listed – out of these, 45 were animal parts, and 30 were minerals.
However, in the case of a contact, the consequences on humanity are the same as in the first scenario. This scenario assumes that all civilizations would have destroyed themselves before any contact. Kardashev estimates the probability of this to be 10%. Humanity should be able to detect ancient megastructures in the vicinity of the nearest stars. As a result, no contact with humanity can take place. The last scenario suggests that we are the first or the only ones in the Universe. Kardashev estimates its probability at 10%. Only exobiology can confirm or falsify such a scenario. We can imagine a potential contact in the distant future, and then the consequences would be similar to those of the other five scenarios.
presented evidence that in natural S. cerevisiae populations clonal reproduction and selfing (in the form of intratetrad mating) predominate. In nature, the mating of haploid cells to form diploid cells is most often between members of the same clonal population and out-crossing is uncommon. Analysis of the ancestry of natural S. cerevisiae strains led to the conclusion that out-crossing occurs only about once every 50,000 cell divisions. These observations suggest that the possible long-term benefits of outcrossing (e.g. generation of diversity) are likely to be insufficient for generally maintaining sex from one generation to the next. Rather, a short-term benefit, such as recombinational repair during meiosis, may be the key to the maintenance of sex in S. cerevisiae. Some pucciniomycete yeasts, in particular species of Sporidiobolus and Sporobolomyces, produce aerially dispersed, asexual ballistoconidia.
Forensic science has been fostered by a number of national and international forensic science learned bodies including the American Academy of Forensic Sciences (founded 1948), publishers of the Journal of Forensic Sciences; the Canadian Society of Forensic Science (founded 1953), publishers of the Journal of the Canadian Society of Forensic Science; the Chartered Society of Forensic Sciences, (founded 1959), then known as the Forensic Science Society, publisher of Science & Justice; the British Academy of Forensic Sciences (founded 1960), publishers of Medicine, Science and the Law; the Australian Academy of Forensic Sciences (founded 1967), publishers of the Australian Journal of Forensic Sciences; and the European Network of Forensic Science Institutes (founded 1995).
Sources: en.wikipedia.org
==== City 17 ==== During the development of Half-Life 2, Antonov was promoted from a concept artist to being the game's art director. He was the principal designer of its dystopian setting of City 17: a decaying Eastern European city in an unspecified location, occupied by the Combine, an alien empire that invaded Earth (during and after the events of the first Half-Life) and established an oppressive world government. City 17 features numerous Soviet-era concrete buildings in the Brutalist style, as well as structures constituting the Combine's surveillance state which are built like a series of panopticons: a type of prison in which a single guard can monitor every prisoner simultaneously from a central tower, but each prisoner is not able to see whether they are being watched. Ted Litchfield writes for PC Gamer that the Combine's "invasive, angular, [and] alien" architecture "latch[es] onto the human architecture underneath like tumors". In the middle of City 17 is the Combine's Citadel, a skyscraper far taller than any of its surroundings, at one to five miles high (according to fan estimates). The empire uses it as a stronghold, to expand its army, and to surveil the city's residents. Half-Life 2's player character Gordon Freeman must travel to and enter the Citadel to damage the Combine's infrastructure. Antonov used Half-Life 2 as an opportunity to game explore an urban Eastern European setting. He felt that such a setting was underused in popular fiction, and that putting it in Half-Life 2 would lead to a "specific, as opposed to generic" aesthetic.
== External links == "Calcitonin Receptors". IUPHAR Database of Receptors and Ion Channels. International Union of Basic and Clinical Pharmacology. Archived from the original on 2016-03-03. Retrieved 2007-07-23. Calcitonin+receptors at the U.S. National Library of Medicine Medical Subject Headings (MeSH)
The Battle of the Philippine Sea was a major naval battle of World War II on 19–20 June 1944 that eliminated the Imperial Japanese Navy's ability to conduct large-scale carrier actions. It took place during the United States' amphibious reconquest of the Mariana Islands during the Pacific War. The battle was the last of five major "carrier-versus-carrier" engagements between American and Japanese naval forces, and pitted elements of the United States Navy's Fifth Fleet against ships and aircraft of the Imperial Japanese Navy's Mobile Fleet and nearby island garrisons. The battle was the largest carrier-to-carrier engagement in history, involving 24 aircraft carriers, deploying roughly 1,350 carrier-based aircraft. The aerial part of the battle was nicknamed the Great Marianas Turkey Shoot by American aviators for the severely disproportional loss ratio inflicted upon Japanese aircraft by American pilots and anti-aircraft gunners. During a debriefing after the first two air battles, a pilot from USS Lexington remarked "Why, hell, it was just like an old-time turkey shoot down home!" The outcome is generally attributed to a wealth of highly trained American pilots with superior tactics and numerical superiority, and new anti-aircraft ship defensive technology (including the top-secret anti-aircraft proximity fuze), versus the Japanese use of replacement pilots with not enough flight hours in training and little to no combat experience.
CD33 has now emerged as the primary target for novel drug discovery programs aimed at curbing neuroinflammation, at over a dozen pharmaceutical and biotech companies. Other AD genes Tanzi has discovered include ADAM10, UBQLN1, IDE, A2M, ITGB3, and ATXN1. In 2020, he used multiple whole genome sequencing datasets for the first time to identify sex-specific genetic risk factors for AD (ZBTB7C, GRID1, RIOK3, MCPH1) as well as several novel Alzheimer's disease-associated rare variants in loci related to synaptic function and neuronal development (FNBP1L, SEL1L, LINC00298, PRKCH, C15ORF41, C2CD3, KIF2A, APC, LHX9, NALCN, CTNNA2, SYTL3, CLSTN2, DTNB, DLG2). In 2022, Tanzi and colleagues whole-genome sequencing to discover two new genes associated with Alzheimer's disease: DTNB and DLG2. Over the past three decades, Tanzi has also contributed to the development of novel therapeutics for AD. In 2000, Tanzi and the late Dr. Steven Wagner discovered a class of Alzheimer’s drugs that they termed "gamma secretase modulators (GSM)". GSM's reverse the Abeta42:Abeta40 ratio and thereby prevent amyloid plaques. Notably, they do not inhibit gamma-secretase. Tanzi and Wagner have published several papers on these compounds. Their GSM is now slated for AD clinical trials in 2026 with Acta Pharmaceuticals. In 2014, Tanzi, and his ex-trainees, Doo Yeon Kim and Se Hoon Choi, were the first to use human stem cells to create three-dimensional cell culture organoids of AD, dubbed by The New York Times as “Alzheimer's-in-a-Dish”.
Sources: en.wikipedia.org
TB-500 is a synthetic heptapeptide corresponding to a fragment of thymosin beta-4. It is used in laboratory research and is not an approved drug.
No. Thymosin beta-4 is a 43-amino-acid protein, while TB-500 represents only a short N-terminal segment. The two should not be treated as interchangeable in experimental design.
It is often called a thymosin beta-4 fragment, Tβ4 fragment, or Ac-LKKTETQ. The name TB-500 is mainly a commercial or catalog label rather than a formal chemical name.
Standard practice is a desiccated container at −20 °C, protected from light and kept sealed between uses. Letting the vial reach room temperature before opening reduces condensation on the powder. Repeated warming and cooling of the whole container is generally avoided.